A growing cottage industry is dedicated to the theory that mind-altering drugs can improve business leadership.
Related Posts
‘It’s All About Trump’s Tariffs’: Asia Flocks to U.S. Trade Official
Asia Pacific Economic Cooperation nations, staring down U.S. tariffs, jockeyed for time with U.S. Trade Representative Jamieson Greer at a gathering in South Korea.
Honda and Nissan Scrap $50 Billion Merger Plan
The Japanese companies’ decision to call off negotiations highlights the challenges legacy automakers face in partnering to tackle new technologies.
A New Trump Administration Is No Reason to Change Investing Plans
Big changes are coming in the next Trump administration. But your investing plans needn’t change, our columnist says.